# CNO Financial Group, Inc.: overview

CNO · NYSE · CIK 1224608 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cno.md) · [Financials](/companies/cno/financials.md) · [Filings](/companies/cno/filings.md) · [Insiders](/companies/cno/insiders.md)

Latest reported revenue: [$1.29bn](/filings/0001224608-26-000064.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0001224608-26-000064).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,130](/filings/0001224608-26-000017.md) | [1,097](/filings/0001224608-26-000017.md) | [1,004](/filings/0001224608-26-000041.md) | [1,152](/filings/0001224608-26-000064.md) | [1,189](/filings/0001224608-26-000017.md) | [1,143](/filings/0001224608-26-000017.md) | [1,030](/filings/0001224608-26-000041.md) | [1,285](/filings/0001224608-26-000064.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [13.6%](/filings/0001224608-25-000070.md) | [15.8% d](/filings/0001224608-26-000017.md) | [10.4%](/filings/0001224608-26-000041.md) | [9.8%](/filings/0001224608-26-000064.md) | [13.7%](/filings/0001224608-25-000070.md) | [15.2% d](/filings/0001224608-26-000017.md) | [12.6%](/filings/0001224608-26-000041.md) | [11.7%](/filings/0001224608-26-000064.md) |
| Net margin | % | [0.8%](/filings/0001224608-26-000017.md) | [16.7%](/filings/0001224608-26-000017.md) | [2.1%](/filings/0001224608-26-000041.md) | [8.0%](/filings/0001224608-26-000064.md) | [1.9%](/filings/0001224608-26-000017.md) | [8.1%](/filings/0001224608-26-000017.md) | [3.7%](/filings/0001224608-26-000041.md) | [9.8%](/filings/0001224608-26-000064.md) |
| Diluted EPS | $ per share | [0.09](/filings/0001224608-26-000017.md) | [1.74](/filings/0001224608-26-000017.md) | [0.21](/filings/0001224608-26-000041.md) | [0.91](/filings/0001224608-26-000064.md) | [0.24](/filings/0001224608-26-000017.md) | [0.95](/filings/0001224608-26-000017.md) | [0.39](/filings/0001224608-26-000041.md) | [1.33](/filings/0001224608-26-000064.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,122](/filings/0001224608-24-000009.md) | [3,577](/filings/0001224608-25-000006.md) | [4,147](/filings/0001224608-26-000017.md) | [4,450](/filings/0001224608-26-000017.md) | [4,487](/filings/0001224608-26-000017.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [12.5%](/filings/0001224608-24-000009.md) | [13.0%](/filings/0001224608-25-000006.md) | [11.1%](/filings/0001224608-26-000017.md) | [12.4%](/filings/0001224608-26-000017.md) | [12.3%](/filings/0001224608-26-000017.md) |
| Net margin | % | [13.8%](/filings/0001224608-24-000009.md) | [17.6%](/filings/0001224608-25-000006.md) | [6.7%](/filings/0001224608-26-000017.md) | [9.5%](/filings/0001224608-26-000017.md) | [5.1%](/filings/0001224608-26-000017.md) |
| Diluted EPS | $ per share | [4.35](/filings/0001224608-24-000009.md) | [5.36](/filings/0001224608-25-000006.md) | [2.40](/filings/0001224608-26-000017.md) | [3.89](/filings/0001224608-26-000017.md) | [2.30](/filings/0001224608-26-000017.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cno/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $682.4m | 13,386,295 |  | Added +331,648 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $343.4m | 6,735,592 |  | Added +814 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $211.9m | 4,156,957 |  | Added +142,827 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $208.1m | 4,081,392 |  | Reduced −23,090 |
| [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $197.4m | 3,872,719 |  | Reduced −56,718 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $191.5m | 3,755,956 |  | Added +172,666 |
| [FULLER & THALER ASSET MANAGEMENT, INC.](/funds/1082327.md) | 2026-06-30 | $181.0m | 3,551,078 |  | Reduced −201,914 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $172.7m | 3,387,446 |  | Reduced −8,283 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $137.4m | 2,695,882 |  | Added +1,175,283 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $133.8m | 2,623,422 |  | Added +115,701 |

## Recent filings

[All 1,779 filings](/companies/cno/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-01 | 08:49 ET | [8-K](/filings/0001224608-26-000071.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001224608-26-000071 |
| 2026-08-06 | 16:14 ET | [10-Q](/filings/0001224608-26-000064.md) | Quarterly report, period 2026-06-30 | 0001224608-26-000064 |
| 2026-07-30 | 16:16 ET | [8-K](/filings/0001224608-26-000061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001224608-26-000061 |
| 2026-05-13 | 16:53 ET | [8-K](/filings/0001224608-26-000057.md) | 5.07 Shareholder vote results | 0001224608-26-000057 |
| 2026-05-07 | 16:21 ET | [10-Q](/filings/0001224608-26-000041.md) | Quarterly report, period 2026-03-31 | 0001224608-26-000041 |
| 2026-04-30 | 16:21 ET | [8-K](/filings/0001224608-26-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001224608-26-000038 |
| 2026-03-26 | 16:13 ET | [DEF 14A](/filings/0001224608-26-000029.md) | Proxy statement, period 2026-03-26 | 0001224608-26-000029 |
| 2026-02-24 | 16:54 ET | [10-K](/filings/0001224608-26-000017.md) | Annual report, period 2025-12-31 | 0001224608-26-000017 |
| 2026-02-11 | 16:17 ET | [8-K](/filings/0001224608-26-000011.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001224608-26-000011 |
| 2026-02-05 | 16:16 ET | [8-K](/filings/0001224608-26-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001224608-26-000008 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001224608-26-000017.md), filed Feb 24, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/0ebf46e6-6b87-458a-a0fa-fddc8b874aa4)

## About the filer

- CIK: 1224608
- Tickers: CNO, CNO-PA
- Exchange: NYSE
- SIC code: 6321 Accident & Health Insurance
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:21 ET. No prices; not investment advice.